Synapse Research Institute

Synapse Research Institute Development & Sales of purified clotting factors, assays and more. Research in the field of the (patho-)physiology of haemostasis and thrombosis.

Synapse BV was founded as a working group within the Cardiovascular Research Institute Maastricht (CARIM) as well as a company within the Maastricht University Holding. In 2009 Synapse BV became member of the STAGO Diagnostica group. It carries out developmental research in the field of the (patho-)physiology of haemostasis and thrombosis, operating in the niche between biochemistry and molecular biology on the one side and pharmaceutical- and clinical sciences on the other. It more specifically explores the overall function of the thrombin generating system in platelet poor- and platelet rich plasma and blood as a diagnostic tool and a pharmaceutical target. It cooperates with major pharmaceutical and diagnostic companies on such subjects as the mechanism of action of antiplatelet drugs and clotting factor inhibitors, the measurement of their effects in vitro and in vivo in animals and humans, as well as the development of diagnostic procedures based on the assessment of the overall function of the coagulation mechanism.

Adres

Koningin Emmaplein 7
Maastricht
6217KD

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer Synapse Research Institute nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Contact De Praktijk

Stuur een bericht naar Synapse Research Institute:

Delen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

Synapse Research Institute was founded as a working group within the Cardiovascular Research Institute Maastricht (CARIM) as well as a company within the Maastricht University Holding. In 2009 Synapse BV became member of the STAGO Diagnostica group. It carries out developmental research in the field of the (patho-)physiology of haemostasis and thrombosis, operating in the niche between biochemistry and molecular biology on the one side and pharmaceutical- and clinical sciences on the other. It more specifically explores the overall function of the thrombin generating system in platelet poor- and platelet rich plasma and blood as a diagnostic tool and a pharmaceutical target. It cooperates with major pharmaceutical and diagnostic companies on such subjects as the mechanism of action of antiplatelet drugs and clotting factor inhibitors, the measurement of their effects in vitro and in vivo in animals and humans, as well as the development of diagnostic procedures based on the assessment of the overall function of the coagulation mechanism.